Peter Llewellyn-Davies

Peter Llewellyn-Davies

Director/Board Member presso SHIELD THERAPEUTICS PLC

Patrimonio netto: 4 549 $ in data 31/03/2024

66 anni
Health Technology
Commercial Services
Finance

Profilo

Peter Llewellyn-Davies is the founder of Acceleration Partners LLC.
He currently holds the position of Chief Executive Officer at invIOs Holding AG, Chairman-Management Board at Biotechnologie-Industrie-Organisation Austria, Independent Non-Executive Director at Shield Therapeutics Plc, and Chief Executive & Financial Officer at APEIRON Biologics AG.
Previously, he held positions such as Executive Director-Finance at Süd-Chemie AG, Managing Director at Müller Dairy (UK) Ltd., Director at Catherex, Inc., Chief Financial Officer & Executive Director at Wilex, Inc., Non-Executive Director at Immunocore Holdings Plc, Member-Supervisory Board at 2invest AG, Chief Financial Officer at CoreOptics GmbH, Chief Financial & Business Officer at MediGene AG, and Chief Financial Officer at Heidelberg Pharma AG.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
31/12/2022 177 842 ( 0.02% ) 4 549 $ 31/03/2024

Posizioni attive di Peter Llewellyn-Davies

SocietàPosizioneInizio
SHIELD THERAPEUTICS PLC Director/Board Member 01/02/2016
Chief Executive Officer 15/07/2018
invIOs Holding AG Chief Executive Officer 01/12/2021
Biotechnologie-Industrie-Organisation Austria Chief Executive Officer 01/12/2020
Tutte le posizioni attive di Peter Llewellyn-Davies

Precedenti posizioni note di Peter Llewellyn-Davies

SocietàPosizioneFine
2INVEST AG Director/Board Member 28/01/2021
MEDIGENE AG Director of Finance/CFO 31/03/2016
HEIDELBERG PHARMA AG Director of Finance/CFO 10/10/2012
Founder -
Director of Finance/CFO -
Vedi nel dettaglio l'esperienza di Peter Llewellyn-Davies

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Peter Llewellyn-Davies

Relazioni

68

Relazioni di 1° grado

14

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa5
2INVEST AG

Finance

MEDIGENE AG

Health Technology

HEIDELBERG PHARMA AG

Health Technology

SHIELD THERAPEUTICS PLC

Health Technology

IMMUNOCORE HOLDINGS PLC

Health Technology

Aziende private9

Electronic Technology

Process Industries

Consumer Non-Durables

Health Technology

Commercial Services

Health Services

Commercial Services

invIOs Holding AG

Biotechnologie-Industrie-Organisation Austria

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Peter Llewellyn-Davies